Trial of ZD1839 (Iressa) and Tamoxifen in Breast Cancer Patients
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Iressa|DRUG: Tamoxifen
Sponsor: Baylor Breast Care Center
Collaborators: AstraZeneca